China SXT Pharmaceuticals, Inc. financial statements, including revenue, expenses, and profit
The total revenue of SXTC for the last semiannual is 829.49 k USD, and it's 16.12% lower compared to the previous semiannual. The net income of H1 24 is -802.57 k USD.